Mental and neurological disorders are increasingly gaining stature on the global health agenda. Visit our dedicated section for media and latest information.
An easy-to-use, practical guide to help individuals and their health professionals reduce the risk of non-communicable diseases
IFPMA companies are helping to defeat NTDs, through programs that increase research, improve access to treatment and strengthen local healthcare capacity
IFPMA expands its Code of Practice and updates the ethical and professional standards for interactions with the healthcare community
Your source for clinical trials information on the web
In Focus
21 May 2012, Geneva, Switzerland
The Annual IFPMA Reception on the occasion of the 65th World Health Assembly
IFPMA cordialy invites you to the annual IFPMA Reception on the occasion of the 65th World Health Assembly.
The theme of this year's event is ‘Putting Children at the Heart of the Decade of Vaccines.’
News
10 May 2012,
New report offers a blueprint to boost research and development (R&D) for diseases of the...
01 March 2012,
Expanded Code of Practice for pharmaceutical industry updates ethical and professional standards...
30 January 2012,
Research-based pharmaceutical industry pledges 14 billion treatments to help end nine neglected...
Events
21 May 2012, Geneva, Switzerland
The Annual IFPMA Reception on the occasion of the 65th World Health Assembly
03 May 2012, Accra, Ghana
3rd African Regulatory Conference (ARC) - Partnering for earlier access to good quality medicines...
Resources
IFPMA Developing World Health Partnerships Directory
Your source for the research-based pharmaceutical industry’s long-term health partnerships programs...

IFPMA Clinical Trials Portal
Your source for clinical trials information on the Web. Find ongoing and completed trials of new...

IFPMA Code of Practice
Expanded IFPMA Code of Practice updates ethical and professional standards for interacting with...
